The Sapien M3 transcatheter mitral valve replacement system won FDA approval -- making it the first on the market to utilize ...
Interventionalists don’t often order a CXR ahead of time, but when it’s already been done, some find the added info useful.
A higher pulmonary vascular resistance index during exercise, but not at rest, predicts poor clinical outcomes in adults with ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
MedPage Today on MSN
Pulsed Field Ablation Safety Issues: Will Newer Devices Clear the Stumbling Block?
After approval in late 2024, Johnson & Johnson's Varipulse PFA system started 2025 on the wrong foot: Its early rollout had ...
I am a 76-year-old male who is in relatively good health. For the past six months, I have been experiencing diarrhea on and ...
Here are the largest medtech funding rounds — all of which equaled or exceeded $150 million — of 2025: Waltham, Massachusetts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback